P06276 |
CHLE_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P06276 |
CHLE_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
P06276 |
CHLE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P06276 |
CHLE_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P06276 |
CHLE_HUMAN |
Eexposure to noxious substances harmful effect [ICD-11: NE61] |
P06276 |
CHLE_HUMAN |
Toxicity [ICD-11: N.A.] |
P06276 |
CHLE_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P11511 |
CP19A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P11511 |
CP19A_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P11511 |
CP19A_HUMAN |
Oesophagitis [ICD-11: DA24] |
P11511 |
CP19A_HUMAN |
Endometriosis [ICD-11: GA10] |
P11511 |
CP19A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P11511 |
CP19A_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P11511 |
CP19A_HUMAN |
Prostate disease [ICD-11: GA91] |